EO2 Concepts (EO2), is an advanced wound care technology company.
Principal Investigator(s)
Botero
Funded by
EO2
Collaborating Institutions
Gonzaba Medical Group, San Antonio, TX
During a retrospective study over a period of 20 months in a wound care clinic, the efficacy of using continuous diffusion of oxygen via the TransCu O2 oxygen delivery system in the treatment of toe ulcerations was assessed. The patients in the study received continuous diffusion of oxygen therapy at rates between 3 and 10 mL/hr underneath a moisture balancing dressing, and clinicians attempted to use compression when appropriate.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Giavedoni, Luis D.
Funded by
Beth Israel Deaconess Med Ctr
TxBiomed is processing Luminex assays for a service fee.
EO2 Concepts (EO2), is an advanced wound care technology company.
Principal Investigator(s)
Mark Couture, DPM
Funded by
EO2
Collaborating Institutions
Central Texas Veteran’s Healthcare Administration, Temple, TX
The purpose of this project is to describe healing outcomes in the VA for the treatment of chronic ulcers using Continuous Diffusion of Oxygen therapy (CDO). CDO is a form of moist wound therapy whereby pure oxygen is added within the moist wound therapy dressing using a portable system. The system used for this study will be the TransCu O2 System, which consists of a handheld oxygen generator, a cannula for delivering the oxygen to the wound and moist wound therapy dressings. In other words, CDO is moist wound therapy with added pure oxygen supplied continuously.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Carrion, Ricardo
Funded by
SAIC-Frederick
The Subcontractor shall furnish the necessary ABSL-4 non-human primate facility equipment and caging, management oversight and personnel for the performance of laboratory animal support services, and select BSL4 challenge material (filoviruses e.g. Ebola, Marburg) to test various novel compounds against filovirus infection.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Carrion, Ricardo
Funded by
Fisher BioServices
TxBiomed will furnish the necessary services, qualified personnel, material, equipment and facilities to perform vaccine testing using the Sudan GP virus.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Hayhurst, Andrew
Funded by
NIH-PMS
Mining recombinant antibody libraries for binders that function well together in an immunoassay is a critical component of developing diagnostics for infectious disease agents and assays for host biomarkers to study disease processes. While identifying antibodies that bind the antigen of interest is reasonably straightforward, combining them in a sandwich assay demands protein purification and in vitro modification, processes that rapidly escalate costs and time when pairing hundreds of potential clones.
